Safety and efficacy of linezolid and azithromycin in the treatment of multidrug-resistant tuberculosis

被引:0
|
作者
Agarwal, Sudhir K. [1 ]
Kumar, Deependra [1 ]
机构
[1] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India
关键词
D O I
10.1016/S0012-3692(16)51509-8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:95S / 95S
页数:1
相关论文
共 50 条
  • [31] Linezolid for multidrug-resistant tuberculosis: How should we approach it?
    Santin, Miguel
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2016, 34 (02): : 83 - 84
  • [32] Can Intermittent Dosing Optimize Prolonged Linezolid Treatment of Difficult Multidrug-Resistant Tuberculosis?
    Chang, Kwok-Chiu
    Yew, Wing-Wai
    Cheung, Siu-Wai
    Leung, Chi-Chiu
    Tam, Cheuk-Ming
    Chau, Chi-Hung
    Wen, Peter Kin-Ho
    Chan, Raphael Chiu-Yeung
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) : 3445 - 3449
  • [33] Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis
    Park, I-Nae
    Hong, Sang-Bum
    Oh, Yeon-Mok
    Kim, Mi-Na
    Lim, Chae-Man
    Lee, Sang Do
    Koh, Younsuck
    Kim, Woo Sung
    Kim, Dong Soon
    Kim, Won Dong
    Shim, Tae Sun
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (03) : 701 - 704
  • [34] Retrospective study of tolerability and efficacy of linezolid in patients with multidrug-resistant tuberculosis (1998-2014)
    Ramirez-Lapausa, Marta
    Pascual Pareja, Jose Francisco
    Carrillo Gomez, Raquel
    Martinez-Prieto, Monica
    Gonzalez-Ruano Perez, Patricia
    Noguerado Asensio, Arturo
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2016, 34 (02): : 85 - 90
  • [35] Bedaquiline, Pretomanid, and Linezolid for Multidrug-Resistant Tuberculosis Treatment in the United States: A BIG Deal
    Acuna-Villaorduna, Carlos
    Sinha, Pranay
    [J]. CLINICAL INFECTIOUS DISEASES, 2023, 77 (07) : 1063 - 1064
  • [36] Discovery of a Conformationally Constrained Oxazolidinone with Improved Safety and Efficacy Profiles for the Treatment of Multidrug-Resistant Tuberculosis
    Zhao, Hongyi
    Wang, Bin
    Fu, Lei
    Li, Gang
    Lu, Haijia
    Liu, Yuke
    Sheng, Li
    Li, Yan
    Zhang, Baoxi
    Lu, Yang
    Ma, Chen
    Huang, Haihong
    Zhang, Dongfeng
    Lu, Yu
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (17) : 9316 - 9339
  • [37] Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment
    Winters, Nicholas
    Butler-Laporte, Guillaume
    Menzies, Dick
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (05) : 1461 - 1470
  • [38] Treatment Outcomes in Multidrug-Resistant Tuberculosis
    Guenther, Gunar
    Lange, Christoph
    Alexandru, Sofia
    Altet, Neus
    Avsar, Korkut
    Bang, Didi
    Barbuta, Raisa
    Bothamley, Graham
    Ciobanu, Ana
    Crudu, Valeriu
    Danilovits, Manfred
    Dedicoat, Martin
    Duarte, Raquel
    Gualano, Gina
    Kunst, Heinke
    de Lange, Wiel
    Leimane, Vaira
    Magis-Escurra, Cecile
    McLaughlin, Anne-Marie
    Muylle, Inge
    Polcova, Veronika
    Popa, Christina
    Rumetshofer, Rudolf
    Skrahina, Alena
    Solodovnikova, Varvara
    Spinu, Victor
    Tiberi, Simon
    Viiklepp, Piret
    van Leth, Frank
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (11): : 1103 - +
  • [39] Linezolid-Resistant Enterococcus faecalis Infection Following Prolonged Low-Dosage Linezolid Treatment for Multidrug-Resistant Tuberculosis
    Baccani, Ilaria
    Antonelli, Alberto
    Galano, Angelo
    Bartalesi, Filippo
    Bartoloni, Alessandro
    Rossolini, Gian Maria
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 65 (12) : 2159 - 2160
  • [40] Surgery in the treatment of multidrug-resistant tuberculosis
    Pomerantz, M
    Brown, JM
    [J]. CLINICS IN CHEST MEDICINE, 1997, 18 (01) : 123 - &